🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human Epidermal Growth Factor Receptor 3 (HER3) expression is seen across a...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-26
Trial ID
NCT01966445
Treatments Being Tested
This study aims to evaluate the efficacy and safety of U3-1402 in participa...
Status
Recruiting
Location
Centre Georges François Leclerc
Start Date
2021-05-11
Trial ID
NCT04965766
Treatments Being Tested
This study is a Phase 1/2, first-in-human, open-label, clinical trial to as...
Status
Recruiting
Location
Research Site
Start Date
2025-12-17
Trial ID
NCT06956690
Treatments Being Tested
The main purpose of • To evaluate the safety, tolerability and pharmacokin...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2020-11-26
Trial ID
NCT05203601
Treatments Being Tested
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Status
Terminated
Location
Chopda Medicare & Research Centre Pvt. Ltd,
Start Date
2025-01-06
Trial ID
NCT06038539
This is a prospective, multicenter, single arm, window-of-opportunity study...
Status
Unknown
Location
ICO Badalona
Start Date
2020-12-22
Trial ID
NCT04610528
This dose-escalating study consists of 3 parts (A, B and C) and will evalua...
Status
Completed
Location
Rigshospitalet, Onkologisk Klinik
Start Date
2011-12
Trial ID
NCT01482377
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
This is a Phase Ib/II multi-center, open-label study of HMBD-001 in combina...
Status
Recruiting
Location
GenesisCare North Shore
Start Date
2024-02-05
Trial ID
NCT05910827
This is an open-label Phase 1 trial of MM-111 in combination with Herceptin...
Status
Completed
Location
Indiana University (IUPUI)
Start Date
2010-04
Trial ID
NCT01097460
Treatments Being Tested